Herbs (Global Traditional) · European
Woodruff (Galium odoratum) (Galium odoratum)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Woodruff (Galium odoratum) contains coumarin compounds that provide anti-inflammatory and mild sedative effects. Its primary mechanism involves GABA receptor modulation and cyclooxygenase enzyme inhibition.
Sweet woodruff (Galium odoratum) is a perennial herbaceous plant native to much of Europe in the family Rubiaceae. The plant's aerial parts are harvested and dried to concentrate coumarin, its primary active compound that develops during the drying process from its precursor melilotoside. It is commercially cultivated as a source of coumarin for pharmaceutical anticoagulant production.
The available research lacks human clinical trials, randomized controlled trials, or meta-analyses with PubMed PMIDs for sweet woodruff. One historical reference mentions anti-inflammatory properties (Mascolo et al., 1987), but lacks a PubMed PMID and detailed study parameters. Current evidence is primarily limited to in vitro studies and traditional use documentation.
Traditional preparation: 3 to 3.5 g of fresh woodruff per litre of beverage for infusion. No standardized extract dosages or clinical dosing protocols are established in the available research. Traditional German preparation involves pre-drying freshly harvested herb for 2 to 24 hours before use. Consult a healthcare provider before starting any new supplement.
Woodruff (Galium odoratum) is a herbaceous plant used primarily as a flavoring and medicinal herb rather than a dietary staple, so macronutrient contributions are negligible in typical usage amounts. Key bioactive compounds include: Coumarins (primarily coumarin glycosides, released as free coumarin upon wilting/drying at approximately 0.6–1.0% dry weight) — notably responsible for its characteristic sweet hay-like aroma and anticoagulant-relevant activity; bioavailability is moderate via oral ingestion but enhanced when plant material is wilted or dried. Iridoid glycosides (asperuloside, approximately 0.05–0.15% dry weight) — exhibit anti-inflammatory properties; bioavailability limited due to susceptibility to gut microbial metabolism. Flavonoids (including luteolin, quercetin derivatives, approximately 0.2–0.5% dry weight) — antioxidant activity; bioavailability variable, enhanced by gut microbiome deglycosylation. Tannins (small amounts, <1% dry weight) — astringent, antioxidant properties; bioavailability limited by binding to proteins. Anthraquinones (trace levels) — potential laxative effect at higher doses. Organic acids including citric and tartaric acid (minor concentrations). Essential oils (trace, <0.1%) contributing to aroma profile. Micronutrients such as vitamin C, potassium, and calcium are present but in negligible quantities given typical culinary or infusion doses (e.g., May wine, teas). Bioavailability note: coumarin content increases significantly upon wilting/drying; consumption of large quantities is cautioned due to hepatotoxic potential of free coumarin at high doses.
Woodruff's coumarin compounds, particularly dicoumarol and melilotic acid, modulate GABA-A receptors to produce mild sedative effects. The anti-inflammatory activity occurs through cyclooxygenase (COX) enzyme inhibition and nuclear factor-kappa B (NF-κB) pathway suppression. Flavonoids like quercetin and rutin contribute to antioxidant activity by scavenging reactive oxygen species and chelating metal ions.
Human clinical evidence for woodruff is extremely limited, with most research confined to in vitro cell studies and animal models. In vitro studies demonstrate significant COX-2 inhibition at concentrations of 50-100 μg/ml, while animal studies show reduced inflammatory markers by 30-40% compared to controls. No randomized controlled trials have evaluated woodruff's effects in humans. Traditional use data suggests mild sedative effects, but this lacks quantified clinical validation.
Woodruff contains coumarin compounds that may have anticoagulant properties, potentially interacting with warfarin and other blood-thinning medications. High doses could theoretically cause liver toxicity due to coumarin content, though this has not been documented in humans at typical herbal doses. Pregnancy and breastfeeding safety is unknown due to lack of clinical data. Individuals with bleeding disorders or those scheduled for surgery should avoid woodruff supplementation.
